Mogamulizumab for relapsed adult T‐cell leukemia–lymphoma: Updated follow‐up analysis of phase I and II studies-Reference-Cited by-同舟云学术

Mogamulizumab for relapsed adult T‐cell leukemia–lymphoma: Updated follow‐up analysis of phase I and II studies

Published:2017-08-28 Issue:10 Volume:108 Page:2022-2029
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Ishida Takashi¹^ORCID,Utsunomiya Atae²,Jo Tatsuro³,Yamamoto Kazuhito⁴,Kato Koji⁵,Yoshida Shinichiro⁶,Takemoto Shigeki⁷^ORCID,Suzushima Hitoshi⁸,Kobayashi Yukio⁹^ORCID,Imaizumi Yoshitaka¹⁰,Yoshimura Kenichi¹¹,Kawamura Kouichi¹²,Takahashi Takeshi¹²,Tobinai Kensei⁹,Ueda Ryuzo¹³

Affiliation:

1. Department of Hematology and Oncology Nagoya City University Graduate School of Medical Sciences NagoyaJapan

2. Department of Hematology Imamura Bun‐in Hospital KagoshimaJapan

3. Department of Hematology Japanese Red Cross Nagasaki Genbaku Hospital NagasakiJapan

4. Department of Hematology and Cell Therapy Aichi Cancer Center Hospital NagoyaJapan

5. Department of Medicine and Biosystemic Science Kyushu University Graduate School of Medical Sciences FukuokaJapan

6. Department of Hematology National Hospital Organization Nagasaki Medical Center NagasakiJapan

7. Department of Hematology and Institute for Clinical Research National Hospital Organization Kumamoto Medical Center KumamotoJapan

8. Department of Hematology Kumamoto Shinto General Hospital KumamotoJapan

9. Department of Hematology National Cancer Center Hospital TokyoJapan

10. Department of Hematology Atomic Bomb Disease and Hibakusha Medicine Unit Atomic Bomb Disease Institute NagasakiJapan

11. Innovative Clinical Research Center Kanazawa University KanazawaJapan

12. Department of Medical Affairs Kyowa Hakko Kirin Co., Ltd Otemachi Financial City Grand Cube TokyoJapan

13. Department of Tumor Immunology Aichi Medical University School of Medicine Nagoya Japan

Funder

Kyowa Hakko Kirin

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.13343

Reference47 articles.

1. International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes

2. The 2016 revision of the World Health Organization classification of lymphoid neoplasms

3. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma.

4. Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting

5. Adult T-cell leukemia: clinical and hematologic features of 16 cases

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transmission of Human T-Cell Leukemia Virus Type 1 From Mother to Child and Adult T-Cell Leukemia/Lymphoma;Reference Module in Biomedical Sciences;2024

2. A treatment strategy to mitigate the adverse effect of pretransplant mogamulizumab on post‐transplant clinical outcome in patients with aggressive ATL;British Journal of Haematology;2023-12-06

3. Advances and challenges of immunotherapies in NK/T cell lymphomas;iScience;2023-11

4. An update on the developments in the treatment of adult T-cell leukemia–lymphoma: current knowledge and future perspective;Japanese Journal of Clinical Oncology;2023-08-17

5. Treatment of Adult T-Cell Leukemia/Lymphoma: Established Paradigms and Emerging Directions;Current Treatment Options in Oncology;2023-06-10